Company Overview of Cell-Medicine, Inc.
Cell-Medicine, Inc. manufactures, markets, and imports/exports pharmaceutical drugs for cancer. It offers autologous formalin-fixed tumor vaccine (AFTVac) that is injected to the patient from whom the cancerous tissue has been surgically resected. The company also conducts clinical trials to investigate the safety and feasibility of AFTVac on liver and brain cancer. Cell-Medicine, Inc. was founded in 2001 and is based in Tsukuba, Japan.
Tsukuba, 305 0047
Founded in 2001
81 29 828 5591
81 29 828 5592
Key Executives for Cell-Medicine, Inc.
Similar Private Companies By Industry
|Merck Serono Co., Ltd.||Asia|
|Alfresa Pharma Corporation||Asia|
|DIA Pharmaceutical Co., Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Bridgewater, NJ | InformaticaPosted: Dec 11
- Princeton, NJ | RGPPosted: Dec 13
- Parsippany, NJ | RGPPosted: Nov 27
- Parsippany, NJ | RGPPosted: Oct 21
Sponsored Financial Commentaries
To contact Cell-Medicine, Inc., please visit www.cell-medicine.com. Company data is provided by Capital IQ. Please use this form to report any data issues.